CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from Operating Activities:
Net loss	$ (12,300,473)	$ (6,336,205)
Adjustment to reconcile net loss to net cash used in operating activities
Share-based compensation	375,239	432,362
Depreciation	111,759	122,525
Impairment loss on operating lease right-of-use asset	3,513,999	0
Loss on disposal of equipment	79,495	0
Change in fair value of warrant liability	(2,030,182)	0
Change in fair value of derivative	(837,146)	0
Change in fair value of convertible note payable	0	87,220
Loss on extinguishment of debt	1,014,368	0
Issuance of shares for financing fee	250,000	0
Amortization of right-of-use lease asset	167,073	570,103
Accretion of convertible notes payable	2,151,136	0
Changes in operating assets and liabilities
Prepaid expenses and other current assets	1,396,410	84,218
Deferred offering costs	0	(655,142)
Other noncurrent assets	(3,500)	0
Accounts payable	2,098,290	1,821,639
Accrued expenses and other current liabilities	1,162,728	317,476
Operating lease liability	121,538	(55,634)
Other noncurrent liabilities	(560,150)	(175,066)
Net cash used in operating activities	(3,289,416)	(3,786,504)
Cash flows from investing activities
Purchase of property and equipment	0	(128,454)
Net cash used in investing activities	0	(128,454)
Cash flows from Financing Activities:
Proceeds from issuance of common shares	105,317	1,152,163
Proceeds from exercise of warrants	1,025,000	0
Proceeds from convertible notes payable	2,195,034	1,250,000
Payment of debt issuance costs	(125,803)	0
Proceeds from net shareholder contributions	0	1,250,298
Repayment of insurance financing payable	(921,576)	0
Proceeds from related party loan	250,000	523,044
Net cash provided by financing activities	2,527,972	4,175,505
Net (decrease) increase in cash and cash equivalents	(761,444)	260,547
Effect of exchange rate changes on cash and cash equivalents	21,288	(28,623)
Cash and cash equivalents, beginning of year	894,591	442,477
Cash and cash equivalents, end of year	154,435	674,401
Components of cash, cash equivalents and restricted cash
Cash and cash equivalents	94,435	437,401
Restricted cash	60,000	237,000
Total cash, cash equivalents and restricted cash	154,435	674,401
Non-cash investing and financing activities:
Exchange of related party loans for convertible notes, related party	1,130,775	0
Fair value of warrants issued with convertible notes, related party	786,967	0
Fair value of warrants issued with convertible notes	1,615,194	0
Fair value of derivative issued with convertible notes	849,146
Fair value of warrants exercised and reclassified to additional paid in capital	761,568
Operating lease liabilities arising from obtaining right of use assets	0	4,189,492
Related party loan entered into for settlement of accrued expenses	$ 0	$ 400,000